Druckenmiller's Big Natera Bet Beat the Market

He's a macro trader who makes big, high-conviction bets and rotates fast. His standout move is piling into cancer-test maker Natera, roughly 18% of his whole portfolio. Over the last 6 months his picks returned 19.2%, beating the S&P 500's ~13% gain.